Publikationen, an denen er mitarbeitet Roberto Rodríguez Jiménez (23)

2023

  1. Dramatic increase of suicidality in children and adolescents after COVID-19 pandemic start: A two-year longitudinal study

    Journal of Psychiatric Research, Vol. 163, pp. 63-67

  2. Emotional processing in patients with single brain damage in the right hemisphere

    BMC Psychology, Vol. 11, Núm. 1

  3. Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities

    Molecular Psychiatry, Vol. 28, Núm. 7, pp. 2645-2673

  4. Social Cognition Mediates the Impact of Processing Speed and Sustained Attention on Global Functioning in Schizophrenia

    Psicothema, Vol. 35, Núm. 1, pp. 87-97

  5. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study

    Journal of Personalized Medicine, Vol. 12, Núm. 2

  2. Biological Role of Nutrients, Food and Dietary Patterns in the Prevention and Clinical Management of Major Depressive Disorder

    Nutrients, Vol. 14, Núm. 15

  3. Corrigendum to “What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak” [J. Psychiatr. Res. 153 (2022) 104–108, (S0022395622003764), (10.1016/j.jpsychires.2022.07.010)]

    Journal of Psychiatric Research

  4. Different Emotional Profile of Health Care Staff and General Population During the COVID-19 Outbreak

    Psychological Trauma: Theory, Research, Practice, and Policy, Vol. 14, Núm. 2, pp. 266-272

  5. Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker

    Journal of International Medical Research, Vol. 50, Núm. 5

  6. Emotional Processing Profile in Patients with First Episode Schizophrenia: The Influence of Neurocognition

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  7. Gut Microbiota Metabolites in Major Depressive Disorder—Deep Insights into Their Pathophysiological Role and Potential Translational Applications

    Metabolites, Vol. 12, Núm. 1

  8. Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology

    Biology, Vol. 11, Núm. 7

  9. Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  10. Nutrition, Epigenetics, and Major Depressive Disorder: Understanding the Connection

    Frontiers in Nutrition, Vol. 9

  11. The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective

    Nutrients, Vol. 14, Núm. 5

  12. What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak

    Journal of Psychiatric Research, Vol. 153, pp. 104-108

2021

  1. Assessment of Antipsychotic Medications on Social Media: Machine Learning Study

    Frontiers in Psychiatry, Vol. 12

  2. Facial affect recognition by patients with schizophrenia using human avatars

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  3. Micrornas as critical biomarkers of major depressive disorder: A comprehensive perspective

    Biomedicines, Vol. 9, Núm. 11